Results 71 to 80 of about 40,986 (311)

Environmental contamination with clostridioides (Clostridium) difficile in Vietnam [PDF]

, 2023
AIMS: To investigate the prevalence, molecular type, and antimicrobial susceptibility of Clostridioides difficile in the environment in Vietnam, where little is known about C. difficile.
Bui, Huong T. T., Bui, Nguyen T., Collins, Deirdre A., Khun, Peng A., Phi, Long D., Riley, Thomas V., Trinh, Luong D., Vu, Quyen T. H.   +7 more
core   +2 more sources

Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit

Nature Network Boston, 2023
Despite enhanced infection prevention efforts, Clostridioides difficile remains the leading cause of healthcare-associated infections in the United States.
A. Miles-Jay, E. Snitkin, Michael Y. Lin, Teppei Shimasaki, M. Schoeny, Christine Fukuda, Thelma E Dangana, Nicholas M Moore, Sarah E. Sansom, Rachel D. Yelin, Pamela B. Bell, Krishna Rao, Micah Keidan, Alexandra K. Standke, C. Bassis, M. Hayden, Vincent B. Young   +16 more
semanticscholar   +1 more source

Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?

International Journal of Infectious Diseases, 2022
Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI) have been updated. However, in addition to the clinical efficacy data, the drug of choice should ideally represent optimal antimicrobial stewardship, with an ...
Marcela Krutova, Mark Wilcox, Ed Kuijper
doaj  

Epidemiology of Clostridioides difficile in South Africa

PLOS ONE, 2021
Background Clostridioides difficile (CD) is the most common healthcare-associated enteric infection. There is currently limited epidemiological evidence on CD incidence in South Africa. Aim To estimate the burden of CD infection (CDI) in the South African public sector between 1 July 2016 and 30 June 2017.
Pieter de Jager, Oliver Smith, Stefan Bolon, Juno Thomas, Guy A. Richards   +4 more
openaire   +5 more sources

Antibiotic stewardship implementation and patient-level antibiotic use at hospitals with and without on-site Infectious Disease specialists. [PDF]

, 2020
Many US hospitals lack Infectious Disease (ID) specialists, which may hinder antibiotic stewardship efforts. We sought to compare patient-level antibiotic exposure at Veterans Health Administration (VHA) hospitals with and without an on-site ID ...
Alexander, Bruce, Beck, Brice F, Goetz, Matthew B, Goto, Michihiko, Livorsi, Daniel J, Lund, Brian C, Nair, Rajeshwari, Ohl, Michael, Perencevich, Eli N, Vaughan Sarrazin, Mary S   +9 more
core   +3 more sources

Cutting edges in Clostridioides difficile infections

Swiss Medical Weekly, 2021
Clostridioides difficile is the most common cause of hospital-acquired diarrhoea and one of the most important causes of hospital-acquired infections. It results in significant morbidity, mortality and economic burden - especially in the context of recurrent infections. After initial antibiotic therapy of a C. difficile infection, recurrence occurs in
Ana Durovic, Sarah Tschudin-Sutter
openaire   +3 more sources

Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection

Gut Microbes, 2020
Fecal microbiota transplantation is now recommended for treating recurrent forms of Clostridioides difficile infection. Recent studies have reported protocols using capsules of either frozen or freeze-dried stool allowing oral administration in in- and ...
Julie Reygner, Christine Charrueau, Johanne Delannoy, Camille Mayeur, Véronique Robert, Céline Cuinat, Thierry Meylheuc, Aurélie Mauras, Jérémy Augustin, Ioannis Nicolis, Morgane Modoux, Francisca Joly, Anne-Judith Waligora-Dupriet, Muriel Thomas, Nathalie Kapel   +14 more
doaj   +1 more source

Identification of a Novel Regulator of Clostridioides difficile Cortex Formation

mSphere, 2021
The Centers for Disease Control has designated Clostridioides difficileC.
Megan H. Touchette, Hector Benito de la Puebla, Carolina Alves Feliciano, Benjamin Tanenbaum, Monica Schenone, Steven A. Carr, Aimee Shen   +6 more
doaj   +1 more source

High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection [PDF]

, 2017
Objectives: Despite multiple risk factors and a high rate of colonization for Clostridium difficile, the occurrence of C. difficile infection in patients with cystic fibrosis is rare.
Acharya, K. Ravi, Hamed, Mohamed R., Humphreys, D.P., MacKenzie, B., Monaghan, Tanya M., Negm, Ola H., Shone, Clifford C., Wilcox, Mark H.   +7 more
core   +2 more sources

Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019 [PDF]

, 2022
BACKGROUND: Since 2008, Danish national surveillance of Clostridioides difficile has focused on binary toxin-positive strains in order to monitor epidemic types such as PCR ribotype (RT) 027 and 078.
Andersen, Leif Percival, Coia, John Eugenio, Engberg, Jørgen, Engsbro, Anne Line, Holt, Hanne Marie, Jensen, Mie Birgitte Frid, Lemming, Lars, Marmolin, Ea Sofie, Nielsen, Eva Møller, Nielsen, Hans Linde, Nielsen, Sofie Holtsmark, Olesen, Bente Scharvik, Persson, Søren, Petersen, Andreas Munk, Søndergaard, Turid Snekloth, Sørensen, Gitte, Wiuf, Camilla   +16 more
core   +1 more source